Left ventricular dysfunction after degenerative mitral valve repair: A question of better molecular targets or better surgical timing?  Jordan D. Miller,

Slides:



Advertisements
Similar presentations
Of mice and men and surgical transcatheter aortic valve insertion
Advertisements

Manuel J. Antunes, MD, PhD, DSc 
Aortic valve replacement in low-flow, low-gradient aortic stenosis: Left ventricular ejection fraction matters  Victor Dayan, MD, PhD, Philippe Pibarot,
Can papillary muscle interventions improve mitral valve repair durability for ischemic mitral regurgitation?  Christos G. Mihos, DO, Orlando Santana,
Is individualized mitral valve repair in the future?
Left ventricular dysfunction after mitral valve repair—the fallacy of “normal” preoperative myocardial function  Eduard Quintana, MD, Rakesh M. Suri,
Moderate mitral regurgitation in aortic root replacement surgery: Comparing mitral repair with no mitral repair  Fenton H. McCarthy, MD, Nimesh D. Desai,
Novel mechanism of mitral regurgitation after lung transplantation in a patient with scleroderma and pulmonary hypertension  Christian A. Bermudez, MD,
Endoscopic Robotic Mitral Valve Surgery
Niv Ad, MD, Rakesh M. Suri, MD, DPhil, James S
Early mitral valve surgery for chronic severe mitral regurgitation optimizes left ventricular performance and left ventricular mass regression  Ken-ichi.
Puja Gaur, MD, Tsuyoshi Kaneko, MD, Siobhan McGurk, BS, James D
Turning to the truth: Is mechanical aortic valve orientation important in transthoracic echocardiographic detection of prosthetic dysfunction and paravalvular.
Timing of valve repair for severe degenerative mitral regurgitation and long-term left ventricular function  Takeshi Kitai, MD, Yukikatsu Okada, MD, Yu.
Prolonged QTc affects short-term and long-term outcomes in patients with normal left ventricular function undergoing cardiac surgery  Nattachai Anantasit,
Is there an outcome penalty linked to guideline-based indications for valvular surgery? Early and long-term analysis of patients with organic mitral regurgitation 
Pulmonary hypertension in valve disease: A beast of the past?
Marc R. Moon, MD  The Journal of Thoracic and Cardiovascular Surgery 
A new approach: Ischemic mitral regurgitation guidelines by and for surgeons  Patrick M. McCarthy, MD  The Journal of Thoracic and Cardiovascular Surgery 
Functional mitral stenosis after mitral valve repair is a true anatomic problem that originates from the time of surgery  Vincent Chan, MD, MPH, Thierry.
Hassane Abdallah, MD, Alaae Boutayeb, MD, Gebrine El Khoury, PhD 
The lord of the rings  Antonio Miceli, MD, PhD 
Is individualized mitral valve repair in the future?
Baseline left ventricular function and surgical annular stiffening to predict outcome and reverse left ventricular remodeling after undersized annuloplasty.
Natural history of coexistent tricuspid regurgitation in patients with degenerative mitral valve disease: Implications for future guidelines  Andrew B.
The variability of the mitral valve anatomy and terminology
Does the degree of preoperative mitral regurgitation predict survival or the need for mitral valve repair or replacement in patients with anomalous origin.
A near 100% repair rate for mitral valve prolapse is achievable in a reference center: Implications for future guidelines  Javier G. Castillo, MD, Anelechi.
Innovation and science: The future of valve design
The role of cognitive dissonance in the management of functional tricuspid regurgitation at the time of degenerative mitral valve repair  Rakesh M. Suri,
The assessment of cost effectiveness and the effectiveness of cost assessment in cardiothoracic surgery  Vinay Badhwar, MD  The Journal of Thoracic and.
Long-term clinical results of mitral valvuloplasty using flexible and rigid rings: A prospective and randomized study  Byung-Chul Chang, MD, Young-Nam.
Michele Gallo, MD, Gino Gerosa, MD 
Clinical evaluation of functional mitral stenosis after mitral valve repair for degenerative disease: Potential affect on surgical strategy  Thierry G.
Surgery for aortic and mitral valve disease in the United States: A trend of change in surgical practice between 1998 and 2005  Scott D. Barnett, PhD,
Joseph A. Dearani, MD, Michael J. Ackerman, MD, PhD 
Transient right ventricular dysfunction caused by retractor during lower hemisternotomy mitral valve repair in a patient with pectus excavatum  Homare.
The empire strikes back: Surgical ventricular reconstruction works very well in Japan  Lorenzo A. Menicanti, MD  The Journal of Thoracic and Cardiovascular.
Posterior leaflet mitral valve prolapse: One repair does not fit all
Jeevanantham Rajeswaran, PhD, Eugene H. Blackstone, MD 
Fenton H. McCarthy, MD, MS, Nimesh D. Desai, MD, PhD 
Early left ventricular regional contractile impairment in chronic mitral regurgitation occurs in a consistent, heterogeneous pattern  Hersh S. Maniar,
Replicating the success of mitral valve repair in the aortic valve
Marc Licker, MD, John Diaper, RA 
Patient recovery after intermittent disc escape and spontaneous recession of a mechanical heart valve  Francis Robicsek, MD, PhD, Joseph W. Cook, MD 
Passing the torch The Journal of Thoracic and Cardiovascular Surgery
Biomaterials for heart valve replacement: Conjectures and refutations
Patients with unbalanced atrioventricular canal defects can undergo the Fontan operation with good outcomes  Sitaram M. Emani, MD  The Journal of Thoracic.
Commentary: Three-dimensional P3 tethering angle at the heart of future surgical decision making in ischemic mitral regurgitation  Wobbe Bouma, MD, PhD,
Warfarin or aspirin after mitral valve repair: Why work harder?
Mitral regurgitation surgery in patients with ischemic cardiomyopathy and ischemic mitral regurgitation: Factors that influence survival  Simon Maltais,
Constantine L. Athanasuleas, MD, FACC 
The Journal of Thoracic and Cardiovascular Surgery
Discussion The Journal of Thoracic and Cardiovascular Surgery
Severe tricuspid or mitral regurgitation in inoperable patients with aortic stenosis. Can we leave them alone?  Juan A. Crestanello, MD  The Journal of.
Basar Sareyyupoglu, MD, Hartzell V. Schaff, MD, Rakesh M
The future of cardiac surgery training: A survival guide
Another case of underprovision of mitral valve repair surgery: Lessons from the Veterans Affairs health system  Anelechi C. Anyanwu, MD, David H. Adams,
Tricuspid annulus diameter does not predict the development of tricuspid regurgitation after mitral valve repair for mitral regurgitation due to degenerative.
Early surgical intervention versus watchful waiting and outcomes for asymptomatic severe aortic regurgitation  Christophe de Meester, MS, Bernhard L.
Reliability of risk algorithms in predicting early and late operative outcomes in high-risk patients undergoing aortic valve replacement  Todd M. Dewey,
Seeing is believing: A call for routine early postoperative hemodynamic transesophageal echocardiography monitoring after left ventricular assist device.
“The more things change…”: The challenges ahead
Recovery of left ventricular function after surgical correction of mitral regurgitation caused by leaflet prolapse  Rakesh M. Suri, MD, DPhil, Hartzell.
Ryan R. Davies, MD  The Journal of Thoracic and Cardiovascular Surgery 
Preoperative PFTs: The answer is blowing in the wind
Chordal replacement with polytetrafluoroethylene sutures for mitral valve repair: A 25- year experience  Tirone E. David, MD, Susan Armstrong, MSc, Joan.
Selecting patients with mitral regurgitation and left ventricular dysfunction for isolated mitral valve surgery  Constance K. Haan, MD, Cristina I. Cabral,
How do we follow up our patients
Marc Gillinov, MD, Per Wierup, MD, PhD, Stephanie Mick, MD 
Presentation transcript:

Left ventricular dysfunction after degenerative mitral valve repair: A question of better molecular targets or better surgical timing?  Jordan D. Miller, PhD, Rakesh M. Suri, MD, DPhil  The Journal of Thoracic and Cardiovascular Surgery  Volume 152, Issue 4, Pages 1071-1074 (October 2016) DOI: 10.1016/j.jtcvs.2016.07.018 Copyright © 2016 The American Association for Thoracic Surgery Terms and Conditions

Figure 1 Prevalence and potential mechanisms of postoperative left ventricular (LV) dysfunction. Note that roughly 20% of patients develop postoperative LV dysfunction, with the magnitude of that impairment being predictive of the likelihood of recovery of function. While numerous mechanisms have been proposed to underlie the transient impairment of LV function and its return to preoperative levels, few have been tested experimentally. Consequently, further research using experimental model systems to identify druggable molecular targets combined with multi-site, large-scale clinical studies to identify suitable biomarkers to trigger early intervention will be key to improving postoperative outcomes for all patients undergoing mitral valve repair surgery. MR, Mitral regurgitation; EF, ejection fraction; β-AR, β-adrenergic receptor. The Journal of Thoracic and Cardiovascular Surgery 2016 152, 1071-1074DOI: (10.1016/j.jtcvs.2016.07.018) Copyright © 2016 The American Association for Thoracic Surgery Terms and Conditions

Prevalence and potential mechanisms of postoperative left ventricular dysfunction. The Journal of Thoracic and Cardiovascular Surgery 2016 152, 1071-1074DOI: (10.1016/j.jtcvs.2016.07.018) Copyright © 2016 The American Association for Thoracic Surgery Terms and Conditions